364.1 Survival benefit of living donor availability for pediatric liver transplantation in a large North American center: An intention-to-treat analysis.
Dr. Blayne Amir Sayed, Canada
364.2 Key considerations for enhancing postoperative prognosis in pediatric liver transplantation: Results from a single center cohort study
Dr. Artem R. Monakhov, Russian Federation
364.3 Risk factors and outcomes of neutropenia following pediatric liver transplantation
Dr. F. Burcu Belen Apak, Turkey
364.4 Long-term social outcomes of pediatric liver transplant recipients: Transition from childhood to adulthood
Dr. Adem Safak, Turkey
364.5 Assessment of long term pediatric graft liver volume post living donor liver transplantation
Dr. Yoshihiro Hirata, Japan
364.7 Use of basiliximab with delayed calcineurin inhibitors introduction in living donor liver transplant recipients with renal dysfunction: Lessons we learned
Dr. Milind Mandwar, India
364.8 Quality of life in adult liver transplant
Prof. Carmelo Loinaz, Spain
364.9 Percutaneous management of biliary strictures in liver transplant patients with hepaticojejunostomy
Dr. Ozgur Ozen, Turkey
364.10 Living donor liver transplant in Shiraz, Iran; preliminary analyses of a 20-year experience in children and adults
Dr. Amirali Mashhadiagha, Iran
364.11 Extraanatomic arterial reconstruction during liver transplantation
Dr. Serik Turebaevich Tileuov, Kazakhstan
364.12 Post- transplant diarrhea: is there a need for center specific protocol
Prof. Arpita Ray Chaudhury (Lahiri), India
364.13 Life-saving liver transplant procedure for pediatric and adult patients: Domino liver transplantation
Prof. Sedat Yildirim, Turkey
364.14 (in journal V-113.3) Growth and success of Liver Transplantation in the United Arab Emirates: An interim 6-Year report